- Report
- January 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- August 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- August 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- March 2025
- 182 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- March 2025
- 185 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- March 2025
- 185 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- January 2025
- 180 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- August 2024
- 185 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- August 2024
- 185 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- February 2025
- 187 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- July 2024
- 185 Pages
Global
From €4204EUR$4,500USD£3,556GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- July 2024
- 150 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- July 2024
- 100 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- July 2024
- 100 Pages
Global
From €3503EUR$3,750USD£2,964GBP
- Report
- March 2025
- 150 Pages
Global
From €4531EUR$4,850USD£3,833GBP
- Report
- February 2025
- 150 Pages
Global
From €4531EUR$4,850USD£3,833GBP
- Report
- December 2024
- 150 Pages
Global
From €4531EUR$4,850USD£3,833GBP

The Communicable Disease Control market is a subset of the Infectious Disease Testing market, focusing on the prevention, diagnosis, and treatment of communicable diseases. This market includes products and services such as diagnostic tests, vaccines, and therapeutics. Diagnostic tests are used to detect the presence of a communicable disease, while vaccines are used to prevent the spread of communicable diseases. Therapeutics are used to treat communicable diseases.
The Communicable Disease Control market is driven by the increasing prevalence of communicable diseases, the growing demand for rapid and accurate diagnosis, and the increasing availability of vaccines. Additionally, the increasing focus on public health initiatives and the development of new technologies are expected to drive the market.
Some companies in the Communicable Disease Control market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more